Singapore markets open in 8 hours 29 minutes

Pfizer Inc. (PFE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
50.54-0.80 (-1.56%)
As of 12:31PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close51.34
Bid50.39 x 900
Ask50.40 x 1200
Day's range50.26 - 51.42
52-week range38.48 - 61.71
Avg. volume28,272,935
Market cap283.575B
Beta (5Y monthly)0.72
PE ratio (TTM)13.11
EPS (TTM)3.85
Earnings date26 Jul 2022 - 01 Aug 2022
Forward dividend & yield1.60 (3.12%)
Ex-dividend date12 May 2022
1y target est59.33
  • Editor's pick
    Yahoo Finance Video

    Citi stock up after Berkshire discloses $3 billion stake, FDA approves Pfizer booster for ages 5-11

    Citi shares popped after Berkshire Hathaway announced it had acquired 55 million shares of the company, the FDA approved Pfizer's COVID booster for ages 5-11, and topped Q1 sales estimates despite China lockdowns.

  • Motley Fool

    Why Pfizer Looks Better Than Moderna as a Long-Term Buy

    For a stock to be a strong long-term buy, investors need to have confidence that its business will be able to grow indefinitely. Both Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) are examples of companies that continue to thrive today due to the pandemic with their highly successful COVID-19 vaccines generating billions in sales for their respective companies. COVID-19 revenue has resulted in surging revenue for Pfizer.

  • Zacks

    Moderna (MRNA) Stock Rises 4%: What's Behind the Upside?

    Moderna (MRNA) stock rises more than 4% on May 17. The COVID-19 vaccine-maker attracts investors on the back of a promising update from one of its competitors.